The COVID-19 IgG Antibody Detection Kit (CLIA) is a chemiluminescence immunoassay intended for in vitro quantitative detection of novel coronavirus (SARS-CoV-2) IgG antibodies in human serum samples. It is used in combination with our Full-Automatic Chemiluminescence Immunoassay System (FACIS-I), to simplify the operation procedure and obtain quantitative results.
Characteristics
Specification
12 tests/kit
Stability
The Kit is stable for 1 year at 2-8°C
Advantage
All in one
Integrated reagents and consumables together, more convenient
Unique sample pretreatment system
Using micron film with invention patent for sample pretreatment, easy to operate
Automatic
Fully automatically perform experiment process & date analysis